Clemente-Soto Aldo F, Balderas-Rentería Isaías, Rivera Gildardo, Segura-Cabrera Aldo, Garza-González Elvira, del Rayo Camacho-Corona María
Facultad de Ciencias Químicas, Universidad Autónoma de Nuevo León, Av. Universidad s/n, Ciudad Universitaria, San Nicolás de los Garza, Nuevo León 66451, Mexico.
Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Boulevard del Maestro s/n, Col. Narciso Mendoza, Reynosa, Tamaulipas 88710, Mexico.
Molecules. 2014 Dec 2;19(12):20170-82. doi: 10.3390/molecules191220170.
The isolation and characterization of the lignan meso-dihydroguaiaretic acid (MDGA) from Larrea tridentata and its activity against Mycobacterial tuberculosis has been demonstrated, but no information regarding its mechanism of action has been documented. Therefore, in this study we carry out the gene expression from total RNA obtained from M. tuberculosis H37Rv treated with MDGA using microarray technology, which was validated by quantitative real time polymerase chain reaction. Results showed that the alpha subunit of coenzyme A transferase of M. tuberculosis H37Rv is present in both geraniol and 1-and 2-methylnaphthalene degradation pathways, which are targeted by MDGA. This assumption was supported by molecular docking which showed stable interaction between MDGA with the active site of the enzyme. We propose that inhibition of coenzyme A transferase of M. tuberculosis H37Rv results in the accumulation of geraniol and 1-and 2-methylnaphtalene inside bacteria, causing membrane destabilization and death of the pathogen. The natural product MDGA is thus an attractive template to develop new anti-tuberculosis drugs, because its target is different from those of known anti-tubercular agents.
已证实从三齿拉瑞阿中分离和鉴定出木脂素内消旋二氢愈创木酸(MDGA)及其抗结核分枝杆菌的活性,但尚未有关于其作用机制的文献报道。因此,在本研究中,我们使用微阵列技术对用MDGA处理的结核分枝杆菌H37Rv的总RNA进行基因表达分析,并通过实时定量聚合酶链反应进行验证。结果表明,结核分枝杆菌H37Rv的辅酶A转移酶α亚基存在于香叶醇以及1-和2-甲基萘的降解途径中,而这些途径正是MDGA的作用靶点。分子对接结果支持了这一假设,显示MDGA与该酶的活性位点之间存在稳定的相互作用。我们认为,抑制结核分枝杆菌H37Rv的辅酶A转移酶会导致香叶醇以及1-和2-甲基萘在细菌内积累,从而引起膜不稳定和病原体死亡。因此,天然产物MDGA是开发新型抗结核药物的一个有吸引力的模板,因为其作用靶点与已知抗结核药物不同。